ReviewJournal of hematology & oncology2023
Targeting LAG-3, TIM-3, and TIGIT for cancer immunotherapy.
Letong Cai et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
304 papers cite itlatest 60 shown
this paperpooled ittrialcites it